The Valhalla Foundation awarded Octave Bioscience funding to further develop a biomarker blood test for assessing disease ...

With FDA-requested toxicology reports in hand, Quantum is preparing to seek clearance for stating the first trial of Lucid-MS ...

Zenas Biopharma has acquired global rights to develop BTK inhibitor orelabrutinib to treat progressive forms of multiple ...

For columnist Desiree Lama, being able to laugh at the uncertainty of living with MS reminds her that the disease doesn't ...

Roxy Murray, known as "The Multiple Sclerosis Fashionista," advocates for adaptive fashion that works both professionally and ...

Routine is important, says columnist Ben Hofmeister, but when MS changes your abilities, sometimes you must adapt your ways.

Menopause does not worsen disability progression in women with multiple sclerosis, according to the largest study of its kind ...

Most people with relapsing MS who were treated with Briumvi for six years did not have confirmed disability progression, a ...

Bruce Bebo, executive vice president of research at the National MS Society, says NMSS investments are helping advance MS ...

Increasing blood vitamin D levels with high-dose supplementation shows promise for people with first symptoms suggestive of ...

Topline trial data showed that a higher Ocrevus dose didn't provide more benefit than the standard regimen in people with ...

Simple housekeeping tips and cleaning strategies for people with MS reduce fatigue and keep your home manageable without ...